RECORDATI

Recordati, a Pharmaceutical Preparation Manufacturing company headquartered in Luxembourg, reported approximately 308.2 million kg CO2e in total emissions for 2025. This includes about 36.6 million kg CO2e from Scope 1 emissions, 1.3 million kg CO2e from Scope 2 (market-based), and 270.3 million kg CO2e from Scope 3 emissions. In 2024, total emissions were approximately 346.5 million kg CO2e, with Scope 1 at about 37.3 million kg CO2e, Scope 2 (market-based) at approximately 1.7 million kg CO2e, and Scope 3 at about 307.5 million kg CO2e.

Recordati has set several climate commitments. The company aims to reduce its Scope 1 and Scope 2 GHG emissions by 42% by 2030 from a 2023 base year, and to measure and reduce its Scope 3 emissions. This target has been approved by the Science Based Targets initiative (SBTi) for small and medium-sized enterprises (SMEs). Additionally, Recordati aims to reduce Scope 1 emissions by 30% from a 2021 baseline by 2030, and Scope 2 emissions by 30% from a 2021 baseline by 2030. The company is also committed to achieving 100% renewable electricity purchased for its Group production and packaging sites and annexed offices by 2025.

Emissions data and targets for Recordati are directly reported by the company.